Table 1.
Various total neoadjuvant treatment protocols in the review article
Author | Study design | Treatment group | Primary outcome |
---|---|---|---|
Marco et al 25 |
Nonrandomized |
Group I: neoadjuvant LCRT Group II: Neoadjuvant LCRT – Consolidation CTx 2cycles Group III: Neoadjuvant LCRT – Consolidation CTx 4cycles Group IV: Neoadjuvant LCRT – Consolidation CTx 6cycles |
pCR rate Surgical difficulty Postoperative complication |
Bujko et al 26 |
Randomized |
neoadjuvant LCRT vs. Conolidation CTx following SCRT |
R0 resection |
RAPIDO trial 27 |
Randomized |
neoadjuvant LCRT vs. Conolidation CTx following SCRT |
DFS after 3 years |
Fernandez‐Martos et al 32 | Nonrandomized |
neoadjuvant LCRT vs. Induction CTx followed by LCRT |
pCR rate |
Cercek et al 33 | Retrospective |
neoadjuvant LCRT vs. Induction CTx followed by LCRT |
pCR rate Group I:21%, group II:36% |
CAO/ARO/AIO‐12 trial 35 | Randomized |
Induction CTx followed by LCRT vs. Conolidation CTx following SCRT |
pCR rate |
PROSPECT trial 30 | Randomized |
neoadjuvant LCRT vs. induction CTx with or without RTx |
R0 resection DFS after 3 years |
Abbreviations: CTx, chemotherapy; DFS, disease free survival, RTx, radiotherapy; LCRT, long‐course chemoradiation therapy; pCR, pathologic complete response; SCRT, short‐course chemoradiation therapy.